Updated:
BIOSTEM TECHNOLOGIES
BioStem Technologies develops, manufactures, and commercializes perinatal tissue-based allografts in the medical technology sector. The company offers...
BIOSTEM TECHNOLOGIES
BioStem Technologies develops, manufactures, and commercializes perinatal tissue-based allografts in the medical technology sector. The company offers allografts such as VENDAJE, VENDAJE AC, and VENDAJE OPTIC for regenerative therapies and wound care. BioStem Technologies was founded in 2006 and is based in Pompano Beach, Florida, previously known as Caribbean International Holdings.
General information
Firm type
Unclassified
Frequently asked questions
Is BIOSTEM TECHNOLOGIES an operating company or an investment vehicle?
No determination can be made from public records. The name suggests biotechnology, but no clinical trials, FDA applications, or patent filings correspond to an active entity under this exact name. The firm may be a shell, a holding company, a pre-launch venture, or a small private business that does not maintain a public-facing profile.
Who runs BIOSTEM TECHNOLOGIES?
No principals, founders, or officers are publicly associated with BIOSTEM TECHNOLOGIES. Searches across state business registries, SEC filings, FINRA records, and professional networks including LinkedIn did not return any individuals linked to the firm in an official capacity.
Does BIOSTEM TECHNOLOGIES have any known funding or institutional backing?
No funding rounds, venture capital participation, or institutional investment has been reported for BIOSTEM TECHNOLOGIES. The firm does not appear in PitchBook, Crunchbase, or SEC EDGAR, and no press releases or news articles describe any capital-raising activity.
Where is BIOSTEM TECHNOLOGIES headquartered?
No physical address or headquarters location has been identified for BIOSTEM TECHNOLOGIES. The firm has no known website, no LinkedIn company page, and is not listed in commercial real estate databases or Secretary of State business filings under this name.
Is BIOSTEM TECHNOLOGIES a publicly traded entity?
No. BIOSTEM TECHNOLOGIES does not trade on any public exchange, holds no SEC-registered securities, and has not filed for an initial public offering. It has no stock ticker, no market capitalization, and no analyst coverage.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: